{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:13:30Z","timestamp":1771870410606,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4771,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,4]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Infection is a common adverse event after therapy with nucleoside analogs, including 2\u2010chlorodeoxyadenosine (CdA). However, the incidence of CdA\u2010related infections has been poorly documented. In this study we compare, in the same patient population, the incidence of infectious episodes during the 6\u2010month period before CdA to their incidence during the 6 months after initiating therapy. Ninety\u2010five patients with hematological malignancies were studied. The incidence of infectious episodes almost doubled after CdA (0.87 vs. 0.47 during the pre\u2010CdA period). The following factors were associated with an increased risk of infection after therapy: a history of previous chemotherapy, infection during the pre\u2010CdA period and a diagnosis of chronic lymphocytic leukemia or of non\u2010Hodgkin's lymphoma. Age, neutrophil and lymphocyte count at onset of CdA and time interval between diagnosis and therapy with CdA did not correlate with the infectious risk. The pattern of infections was modified after therapy with an increase of herpes virus infections (1 vs. 8 episodes, <jats:italic>p<\/jats:italic> = 0.04) and of fever of unknown origin (6 vs. 17 episodes, <jats:italic>p<\/jats:italic> = 0.03). In conclusion, a population at high risk for developing infectious complications after CdA therapy can be identified. Specific measures aimed at reducing the incidence of infectious events should concentrate on this population.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb01935.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T18:56:25Z","timestamp":1279479385000},"page":"235-240","source":"Crossref","is-referenced-by-count":36,"title":["Infectious complications after 2\u2010chlorodeoxyadenosine therapy"],"prefix":"10.1111","volume":"56","author":[{"given":"E.","family":"Van Den Neste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delannoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vandercam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bosyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mineur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Montfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Martiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Straetmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Filleul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004193221605"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-3-199302010-00007"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.1994.12.4.788","article-title":"2\u2010CdA is an active salvage therapy in advanced indolent non\u2010Hodgkin's lymphoma","volume":"12","author":"Hoffman M.","year":"1994","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.3.371"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309023291013"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91046-4"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940615)73:12<2953::AID-CNCR2820731212>3.0.CO;2-V"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V83.10.2906.2906","article-title":"2\u2010CdA induces durable remissions and prolonged suppression of CD4 lymphocyte count in patients with hairy cell leukemia","volume":"83","author":"Seymour JF","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood.V83.12.3672.3672","article-title":"Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocytes subsets after treatment with 2\u2010CdA","volume":"83","author":"Juliusson G.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_12_2","volume-title":"NCI Common Toxicity Criteria","year":"1988"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290307"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb00669.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058693"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2694"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.3.733.733"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.1991.9.3.416","article-title":"A phase I clinical trial of 2\u2010CdA in pediatric P. with acute leukemia","volume":"9","author":"Santana VM","year":"1991","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V84.4.1237.1237","article-title":"Complete hematologic remissions induced by 2\u2010chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia","volume":"84","author":"Santana VM","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.671"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109103394"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402033300504"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood.V79.4.882.bloodjournal794882","article-title":"Treatment of hairy cell leukemia with 2\u2010CdA","volume":"79","author":"Estey EH","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01279.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood.V80.9.2203.2203","article-title":"A single cycle of 2\u2010CdA results in complete remission in the majority of patients with hairy cell leukemia","volume":"80","author":"Tallman MS","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08377.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.679"},{"issue":"1","key":"e_1_2_1_28_2","first-page":"462a","article-title":"Low\u2010dose cladribine (2\u2010CdA) (2mg\/m2 S.C. Day 1\u20137) normalizes cytopenia in hairy cell leukemia (HCL) as quick as standard dose with less lymphopenia \u2013 no improvement by GM\u2010CSF","author":"Juliusson G.","year":"1994","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb01935.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb01935.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T22:20:27Z","timestamp":1698358827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb01935.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb01935.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb01935.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}